The Automated Breast Ultrasound Systems Market was estimated at US$ 1.71 Billion in 2022 which is expected to reach US$ 6.34 Billion by the end of 2032, with a CAGR of 14%: Market Decipher

Decipher Market Insights (OPC) Private Limited
Decipher Market Insights (OPC) Private Limited

The Automated Breast Ultrasound Systems Market will reach US$ 6.34 Billion in 2023 growing at an average rate of 14% annually. High prevalence of obesity, age-related hazards, reduced fertility, excessive alcohol use, smoking, leading a sedentary lifestyle, and hormone replacement therapy will expand demand for the Automated Breast Ultrasound Systems market during the projection period.

Pune, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Market decipher has published its latest report - "Automated Breast Ultrasound Systems Market" Size, Statistics, Growth Trend Analysis and Forecast Report, 2022 – 2032. This report provides meticulous insights into key segments, product specifications and analysis, changing trends, and new technologies, considering key features such as gross margin, revenue & cost. It provides key statistics on the market status of the Automated Breast Ultrasound Systems manufacturers, highlighting influential leading players, market scope, and key developments. The report also gives a telescopic view of opportunities and constraints while projecting the growth matrix and global developments with regional insights, and provides noteworthy data for future events, mergers, and acquisitions with trending innovation and business policies and market environment in this market.

Automated Breast Volume Scanner (ABVS) Evoking the Type Segment

The automated breast volume scanner (ABVS) segment is estimated to garner the largest share during the forecast period, ABVS uses a scanner to precisely examine lactiferous ducts and evaluate volumetric breast images with high-frequency ultrasound light. The non-radioactivity, efficiency, repeatability, and 3D reconstruction that this ultrasound system provides are just a few of its many advantages. The demand will rise as patient preference for minimally invasive diagnostic procedures increases. Real-time imaging support makes it possible to direct the system. Other benefits of ABVS include faster, less painful procedures and improved diagnostic precision that enables early breast cancer diagnosis. This technology's outcomes can be utilized for insightful preoperative surgical planning.

Get research insights in detail: Automated Breast Ultrasound Systems Market

Hospitals Segment will Garner Demand in Automated Breast Ultrasound Systems Market

The hospital’s segment accounted for the highest share in 2020 and is anticipated to maintain this trend during the forecast period owing to the growing patient pool, quicker access to medical instruments and equipment, and the presence of skilled people. The use of ABUS in hospitals is gaining traction as a means of meeting patients' diagnostic needs. Increasing awareness among young and middle-aged women to undergo cancer screening tests on a regular basis will drive demand for ABUS and ABVS in these healthcare settings because pregnant women cannot be exposed to mammograms due to the risk of radiation exposure, hospitals are installing ABUS to provide safer diagnostic choices.

The Automated Breast Ultrasound Systems Market Proliferates in North America

North America dominates the global Automated Breast Ultrasound Systems market attributing to the rise in the use of technologically advanced ultrasound systems, higher awareness among the patients, high healthcare expenditure, availability of trained medical professionals, rise in the number of product approvals, and supportive reimbursement policies in the healthcare system as well as a large number of hospitals and clinics.

Get research insights in detail: Automated Breast Ultrasound Systems Market

Recent Developments

• In November 2022, iCAD, Inc., a worldwide medical technology provider offering cutting-edge cancer diagnosis and therapy solutions, and Ferrum Health, a leader in healthcare enterprise AI solutions, have reached an agreement to make iCAD's breast AI solutions available on Ferrum Health's platform.

• In November 2022, in order to completely integrate HeartVista's artificial intelligence systems for chest imaging scans into its MRI equipment, Siemens Healthineers and HeartVista have signed a contract. The two businesses merged their own MRI sequences—also known as methods—into a single automated clinical imaging routine.

In October 2022, Accuray Incorporated announced today that it will present a significant new alternative for enhancing the care of persons with breast cancer in collaboration with C-RAD AB.• In December 2021, Health Canada approved its first domestically developed 3D printed implant Specific 3D mandibular plate.

• In August 2020, Hologic, Inc. purchased a 46.0% stake in SuperSonic Imagine. With the use of Hologic's resources and SuperSonic Imagine's ultrasound technology, the purchase sought to create more effective and cutting-edge products for breast cancer patients.

Customized Report can be procured on Request:

Report Details:
Number of Pages: 220
Number of Tables: 50
Number of Charts and Graphs: 80

Key Companies Covered

• General Electric Company

• Hitachi, Ltd.

• Koninklijke Philips N.V.

• Siemens Healthineers AG

• Telemed Medical Systems

• Canon Medical Systems Corporation

• Fukuda Denshi

• Hologic, Inc.

 Key Report Takeaways:

• Estimation/projections/forecast for revenue (2022 – 2032)

• Data breakdown for every Industry segment (2022 – 2032)

• Gross margin and profitability analysis of companies

• Impact of COVID-19 On the Automated Breast Ultrasound Systems Market

• Business trend and expansion analysis

• Competition analysis/market share

• Product Innovation Listing

• Client list and case studies

• Market entry strategy

Get this research report:

CONTACT: David Correa Decipher Business Insights Pvt. Ltd. 306, Zen Business Center, Wakad, Mumbai- Banglore Highway, Pune - 411057, Maharashtra Email: Website: